Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ibrance
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ibrance 100mg capsules
0801050CBBBABAB
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 100mg tablets
0801050CBBBADAD
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 125mg capsules
0801050CBBBACAC
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 125mg tablets
0801050CBBBAEAE
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 75mg capsules
0801050CBBBAAAA
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
|
Ibrance 75mg tablets
0801050CBBBAFAF
|
Ibrance | Palbociclib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.